Daniel J. DeAngelo
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 262
- Acute Myeloid Leukemia Research 164
- Chronic Myeloid Leukemia Treatments 116
-
- Acute Lymphoblastic Leukemia research 141
- Co-authors
- Richard M. Stone (145 shared papers)Martha Wadleigh (71 shared papers)Ilene Galinsky (50 shared papers)Anjali S. Advani (55 shared papers)Wendy Stock (56 shared papers)Donna Neuberg (51 shared papers)Hagop M. Kantarjian (53 shared papers)Robert J. Soiffer (23 shared papers)
- Journals
- Blood (180 papers)Journal of Clinical Oncology (49 papers)Leukemia (16 papers)American Journal of Hematology (15 papers)Leukemia Research (14 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Daniel J. DeAngelo
436 papers receiving 16.9k citations
Daniel J. DeAngelo's Hit Papers
Peers
Comparison fields: 5 of 132
- Hematology 8.7k
- Genetics 3.7k
- Public Health, Environmental and Occupational Health 4.2k
- Oncology 3.9k
- Immunology 1.8k
Countries citing papers authored by Daniel J. DeAngelo
This map shows the geographic impact of Daniel J. DeAngelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. DeAngelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. DeAngelo more than expected).
Fields of papers citing papers by Daniel J. DeAngelo
This network shows the impact of papers produced by Daniel J. DeAngelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. DeAngelo. The network helps show where Daniel J. DeAngelo may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. DeAngelo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 459 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Hit paper breakdown → | 2006 | 1071 |
| 2 | Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia Hit paper breakdown → | 2016 | 951 |
| 3 | Differentiation and reversal of malignant changes in colon cancer through PPARγ Hit paper breakdown → | 1998 | 886 |
| 4 | Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Hit paper breakdown → | 2009 | 644 |
| 5 | Acute myeloid leukemia ontogeny is defined by distinct somatic mutations Hit paper breakdown → | 2014 | 629 |
| 6 | Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 Hit paper breakdown → | 2004 | 555 |
| 7 | 2010 | 421 | |
| 8 | 2012 | 273 | |
| 9 | 2003 | 245 | |
| 10 | Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study Hit paper breakdown → | 2019 | 242 |
| 11 | 2005 | 236 | |
| 12 | 2012 | 233 | |
| 13 | 2006 | 225 | |
| 14 | 2007 | 221 | |
| 15 | 2011 | 200 | |
| 16 | 2014 | 197 | |
| 17 | 2015 | 187 | |
| 18 | 2011 | 182 | |
| 19 | 2009 | 180 | |
| 20 | 2010 | 170 |
About Daniel J. DeAngelo
Daniel J. DeAngelo is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Genetics and Oncology, having authored 459 papers that have together received 17.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (164 papers), Acute Lymphoblastic Leukemia research (141 papers), Chronic Myeloid Leukemia Treatments (116 papers), Chronic Lymphocytic Leukemia Research (78 papers), CAR-T cell therapy research (59 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Histone Deacetylase Inhibitors Research (36 papers) and Mast cells and histamine (35 papers). The work is most often cited by research in Hematology (8.7k citations), Genetics (3.7k citations), Public Health, Environmental and Occupational Health (4.2k citations), Oncology (3.9k citations) and Immunology (1.8k citations). Daniel J. DeAngelo has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Richard M. Stone, Martha Wadleigh, Ilene Galinsky, Anjali S. Advani, Wendy Stock, Donna Neuberg, Hagop M. Kantarjian, Robert J. Soiffer, Erik Vandendries and D. Gary Gilliland. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, American Journal of Hematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.